Simon Draper (@S1monJDraper) / X

Simon Draper

188 posts

Simon Draper

@S1monJDraper

Professor of Vaccinology and Translational Medicine @UniofOxford | Views own

Oxford, England

draperlab.web.ox.ac.uk

Joined June 2017

Simon Draper
@S1monJDraper
Apr 14, 2025
Exciting data from a human malaria re-challenge model deciphering how humans become immunologically tolerant to falciparum #malaria. Big thanks to fantastic collaborators @spence_lab.
Journal of Experimental Medicine
@JExpMed
Apr 11, 2025
Muñoz Sandoval, Bach, Nahrendorf, Spence et al. @EdinburghUni show that a single #malaria episode reprograms T cell activation to minimize cytotoxicity and injury during subsequent infections. hubs.la/Q03g_jm10 @S1monJDraper
Simon Draper
@S1monJDraper
Jan 23, 2025
@KavliOxford @OptiVivax
Medical Sciences
@OxfordMedSci
Jan 22, 2025
VOLUNTEER OPPORTUNITY - Healthy volunteers needed to take part in a pioneering malaria challenge study to help us find out more about relapsing malaria infections. Join the fight against malaria with us! @OxfordVacGroup @BiochemOxford Find out more👇 ovg.ox.ac.uk/studies/bio006
Simon Draper
@S1monJDraper
Jan 22, 2025
Our group's new BIO-006 clinical trial on #vivax #malaria is recruiting now in Oxford. The first trial in our @OptiVivax consortium. Aiming to assess relapsing malaria infection - check out the link below 👇
Oxford Vaccine Group
@OxfordVacGroup
Jan 22, 2025
NEW | The Oxford Vaccine Group has launched a novel clinical study, BIO-006, to investigate relapsing malaria infections caused by Plasmodium vivax. This unique parasite can remain dormant in the liver for months or years, reactivating to cause repeated malaria infections.
Simon Draper
@S1monJDraper
Dec 11, 2024
Delighted to share our first safety and efficacy data on the RH5.1/Matrix-M blood-stage #malaria #vaccine in 5-17 month old children in Burkina Faso published @TheLancetInfDis.
thelancet.com
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim...
RH5.1/Matrix-M appears safe and highly immunogenic in African children and shows promising efficacy against clinical malaria when given in a delayed third-dose regimen. This trial is ongoing to...
Simon Draper
@S1monJDraper
Oct 28, 2024
Big congrats to @TheBeiLab, @LatyGaye and their team on the first analysis of #RH5 blood-stage #malaria human #mAbs against P. falciparum clinical isolates in Senegal. Encouraging for strain-transcendence. Check out their great paper @Nature_NPJ below👇
Amy Kristine Bei
@TheBeiLab
Oct 24, 2024
So excited for this paper to be published, proud of the amazing hard work that went into it, and so grateful for the amazing collaborations that made it all possible! You can get a glimpse “behind the paper” here: communities.springernature.com/posts/vaccine-…. Stay tuned for Laty’s thread!